SRXH$0.9251-4.61%
SRX Global Inc.
Sector: BeveragesIndustry: Software - ApplicationCountry: USExchange: NYSE
Mkt Cap:$20.56M
Float & O/S:19.87M / 20.27M
Inst Own:3.9%
DilutionScan read 25 of SRX Global Inc.'s SEC filings and found 9 warrant series, 6 convertibles, 1 equity line, 2 S-1 registrations and 4 completed offerings on file for SRXH. The latest dilution event on file is an offering on Aug 27, 2026. Analysis updated Oct 7, 2026.
Signal8 Summary
SRXH
Reverse split, pivot to investment holding
Snapshot
SRX Global just underwent a total business pivot: after revenue collapsed 87% to $6.5M in FY2025, the company completed a 1-for-60 reverse split, renamed itself, and became an AI-branded investment holding vehicle.
What's Happening Right Now
- : Fiscal Q3 2026 results showed $62.9M net asset value ($3.22/share), $36.7M cash, no debt, and a 35% improvement in the quarterly EBITDA loss to $1.6M.
- : Portfolio company Smartkem announced a merger with Ferrox Critical Minerals; SRX Global holds a 4.99% stake in Smartkem.
- : Board authorized a $20M repurchase program for up to 10 million shares, citing a debt-free balance sheet and strong cash position.
- : NYSE American halted the stock and forced a 1-for-60 reverse split after shares closed below $0.10, effective July 6, 2026.
- : SRx Health Solutions closed the EMJX acquisition and renamed itself SRX Global, pivoting from health services to an AI-branded investment platform.
